Statement Of Income And Retained Earnings

Astellas Pharma Inc. - Filing #7725936

Concept 2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-13,490,000,000 JPY
15,600,000,000 JPY
Non-operating income
Non-operating income
303,270,000,000 JPY
121,224,000,000 JPY
Non-operating expenses
Non-operating expenses
4,089,000,000 JPY
2,649,000,000 JPY
Ordinary profit (loss)
285,690,000,000 JPY
134,174,000,000 JPY
Extraordinary income
Extraordinary income
8,476,000,000 JPY
18,141,000,000 JPY
Extraordinary losses
Extraordinary losses
2,594,000,000 JPY
5,438,000,000 JPY
Profit (loss) before income taxes
291,573,000,000 JPY
146,877,000,000 JPY
Income taxes - current
16,035,000,000 JPY
6,426,000,000 JPY
Income taxes - deferred
-21,281,000,000 JPY
2,633,000,000 JPY
Profit (loss)
296,818,000,000 JPY
296,818,000,000 JPY
296,818,000,000 JPY
296,818,000,000 JPY
137,818,000,000 JPY
137,818,000,000 JPY
137,818,000,000 JPY
137,818,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.